unknown
Stage
About
Chip Diagnostics develops exosome-based diagnostic technology that enables minimally invasive detection and monitoring of diseases using nanoscale liquid biopsies targeting extracellular vesicles.
Explore Chip Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.